Top Markets
Coin of the day
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.

NP5
株式のランク #15970
Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in... Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in Bresso, Milano, with a dedicated team of 24 full-time employees. The company's core mission is the discovery and advancement of innovative pharmaceutical products, particularly focusing on new therapies for Central Nervous System (CNS) disorders and pain management. Among its leading candidates, safinamide is currently undergoing Phase III clinical trials for the treatment of Parkinson's disease. Additionally, ralfinamide is being developed as a potential therapy for neuropathic pain. The firm's pipeline further includes a range of projects at various preclinical and clinical development stages, such as HF0220 for neuroprotection, NW-3509 for schizophrenia, and pruvanserin and sarizotan for other CNS conditions.
株価
$15.42
時価総額
$320.83M
変化(1日)
-1.52%
変化(1年)
40.67%
IT
取引 Newron Pharmaceuticals S.p.A. (NP5)

カテゴリー

Newron Pharmaceuticals S.p.A.(NP5)の株価履歴
終値の最高値: $15.42 (2026-09-01)

終値の最安値: $6.42 (2019-07-01)
Newron Pharmaceuticals S.p.A. の株価履歴(2019 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -24.46%
2025 190.90%
2024 71.92%
2023 246.71%
2022 -14.11%
2021 -28.37%
2020 -64.91%
2019 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$548.15 40.18%
US
$1.03K 44.14%
NL
$153.87 538.73%
US
$121.37 -11.93%
AU
$748.60 4.92%
CH